oral+semaglutide+approval Wegovy® pill approved in the US as first oral GLP-1 for weight management ACC 2025: Oral Semaglutide Reduces
Description
Serious but rare complications include acute pancreatitis, severe hypoglycemia (particularly in patients also taking insulin or sulfonylureas), and dehydration from persistent vomiting
The biological mechanisms driving weight regain involve appetite hormones, metabolic adaptation, and underlying genetic predispositions that remain active after medication discontinuation
TP53 mutations in human cancer: database reassessment and prospects for the next decade
doi: 10.1007/s13300013-0044-9
